Skip to main content

Table 4 Variants identified by the NGS panel in this study. Variants of Uncertain Significance

From: Targeted next generation sequencing with an extended gene panel does not impact variant detection in mitochondrial diseases

Patient N°

Age-ranges onset (years) / sex

Gene

Nucleotide change

Protein change

Trait

Concordant phenotype

ExAC frequency

SIFT score

Polyphen 2

Variant reported

Notes

References

34

1–16 / F

KIF1B

c.4682G > A

p.Cys1561Tyr

AD

Yes

< 0.01%

0.02

0.987

No

35

> 16 / F

POLG2

c.390-2A > C

AD

Yes

1

No

+ c.1105A > G htz (polymorphism)

64

> 16 / M

SYNE1

c.23315G > A / c.15337G > A

p.Arg7772Gln / p.Val5113Ile

AR

Yes

< 0.01% < 0.01%

0.01 0.29

0.956 0.968

No Yes

c.15337G > A htz (patient’s daughter)

Neubauer et al., 2017 [17]

66

1–16 / M

AIFM1

c.893G > A

p.Arg298Gln

X-linked

+/−

< 0.01%

0.63

0.402

No

Mild phenotype

Ardissone et al., 2015 [9]

67

> 16 / M

DNA2

c.2862G > C

p.Leu954Phe

AD

Yes

0

0.0

0.669

No

Severe phenotype

71

> 16 / F

KIF5A

c.1248A > T

p.Lys416Asn

AD

Yes

0

0.01

0.935

No

77

> 16 / M

KIF5A

c.2354A > G

p.Glu785Gly

AD

Yes

0

0.0

0.999

No